Prostate Cancer Gene Mapping Marks Medical Breakthrough
by Gina Kolite in Diseases on May 13, 2011
According to a new study published in the journal Nature, prostate cancer researchers has announced a breakthrough with the complete mapping of the genome of the disease, which has high possibility of formulating better treatment for patients.
The study was performed by researchers from Dana Farber Cancer Institute under the Harvard Medical School and the Massachusetts Institute of Technology. The researchers have fully sequenced the seven types of prostate cancer tumors and analyzed each in accordance to the code of the normal tissue. Their findings suggest how genetic mutations hinder the body’s development of proteins which fight cancer cells.
Levi Garraway from Harvard Medical School, the study author and oncologist at Dana Farber Cancer institute said in a statement, “This first whole genome view shows us tantalizing evidence for several new prostate cancer genes that would have remained undiscovered.”
Moreover, the study also gives clues to researchers on how aggressive a particular type of prostate cancer tumor behaves, in a way of administering new screening tests.
The genome study was funded by Howard Hughes Medical Institute, Prostate Cancer Foundation and the National Institutes of Health’s National Human Genome Research Institute.
Related Posts:
